Search Results - "Bahamondes, Valeria"
-
1
Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods
Published in Human reproduction update (01-09-2015)“…Most contraceptive methods present benefits beyond contraception; however, despite a large body of evidence, many healthcare professionals (HCPs), users and…”
Get full text
Journal Article -
2
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives
Published in Human reproduction (Oxford) (01-07-2014)“…STUDY QUESTION Does intensive counselling before insertion and throughout the first year of use have any influence on discontinuation rates due to…”
Get full text
Journal Article -
3
Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil
Published in Contraception (Stoneham) (01-03-2018)“…To assess the contraceptive performance of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among…”
Get full text
Journal Article -
4
Analysing the context and characteristics of legal abortion and comprehensive post-abortion care among adolescents aged 10-14 in a network of sentinel centres in Latin America: a retrospective cross-sectional study, 2016-2020
Published in Sexual and reproductive health matters (31-12-2023)“…Pregnancy-related complications are a substantial source of morbidity and mortality among adolescents in low- and middle-income countries. While the youngest…”
Get full text
Journal Article -
5
Body weight and composition in users of levonorgestrel-releasing intrauterine system
Published in Contraception (Stoneham) (01-10-2012)“…Abstract Background There is little information about body weight and body composition (BC) among users of the levonorgestrel-releasing intrauterine system…”
Get full text
Journal Article -
6
Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system
Published in Archives of gynecology and obstetrics (01-06-2019)“…Purpose The disease status and thromboembolic events in women with systemic lupus erythematosus (SLE), with and without anti-phospholipid syndrome (APS), were…”
Get full text
Journal Article -
7
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg
Published in Human reproduction (Oxford) (01-03-2016)“…Abstract STUDY QUESTION Will the use of levonorgestrel (LNG) 1.5 mg taken at each day of coitus by women who have relatively infrequent sex be an efficacious,…”
Get full text
Journal Article -
8
Length of the endometrial cavity and intrauterine contraceptive device expulsion
Published in International journal of gynecology and obstetrics (01-04-2011)“…Abstract Objective To evaluate the correlation between endometrial cavity length and expulsion rate in acceptors of the TCu380A intrauterine device (IUD) or…”
Get full text
Journal Article -
9
Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth
Published in Fertility and sterility (01-08-2013)“…Objective To measure infants' breast milk intake and infant growth when their mothers initiated either combined oral contraceptive (COC),…”
Get full text
Journal Article -
10
Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic
Published in Human reproduction (Oxford) (10-10-2014)“…STUDY QUESTION What is the contribution of the provision, at no cost for users, of long acting reversible contraceptive methods (LARC; copper intrauterine…”
Get full text
Journal Article -
11
A Randomized Clinical Trial of the Effect of Intensive Versus Non-intensive Counseling on Discontinuation Rates Due to Bleeding Disturbances of Three Long-Acting Reversible Contraceptives
Published in Obstetrical & gynecological survey (01-01-2015)“…ABSTRACTLong-acting reversible contraceptives (LARCs) include the etonogestrel (ENG)–releasing subdermal implant, the levonorgestrel-releasing intrauterine…”
Get full text
Journal Article -
12
New and emerging contraceptives: a state-of-the-art review
Published in International journal of women's health (01-01-2014)“…The first hormonal contraceptive was introduced onto the market in several countries 50 years ago; however, the portfolio of contraceptive methods remains…”
Get full text
Journal Article -
13
IUD self-removal as self-care: Research is needed in low and middle-income countries
Published in Frontiers in Global Women's Health (07-09-2022)Get full text
Journal Article -
14
Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil
Published in Contraception (Stoneham) (01-09-2012)“…Abstract Background Heavy menstrual bleeding (HMB) is the most common complaint of women seeking gynecological care. Treatments included surgical or medical…”
Get full text
Journal Article -
15
Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean section
Published in Contraception (Stoneham) (01-07-2013)“…Abstract Background Despite the high contraceptive effectiveness and noncontraceptive benefits of the levonorgestrel-releasing intrauterine system (LNG-IUS) in…”
Get full text
Journal Article -
16
Long-acting reversible contraceptive (LARCs) methods
Published in Best practice & research. Clinical obstetrics & gynaecology (01-07-2020)“…Unplanned pregnancy (UP) is a public health problem, which affects millions of women worldwide. Providing long-acting reversible contraceptive (LARC) methods…”
Get full text
Journal Article -
17
Intrauterine device use is safe among nulligravidas and adolescent girls
Published in Acta obstetricia et gynecologica Scandinavica (01-04-2021)“…The use of intrauterine devices (IUDs), including the copper-bearing device and the levonorgestrel intrauterine system (LNG-IUS), is safe among nulligravidas…”
Get more information
Journal Article -
18
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system
Published in Contraception (Stoneham) (01-07-2009)“…Abstract Background The levonorgestrel-releasing intrauterine system (LNG-IUS) is a contraceptive method approved for five years of use. However, there is some…”
Get full text
Journal Article -
19
Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate
Published in The European journal of contraception & reproductive health care (01-08-2014)“…Abstract Objectives To compare variations in bone mineral density (BMD) and body composition (BC) in depot-medroxyprogesterone acetate (DMPA) users and…”
Get full text
Journal Article -
20
Potential of LARC to recover loss in satisfied demand for modern contraception after the COVID-19 pandemic: a case scenario analysis of Brazil and Mexico
Published in Revista panamericana de salud pública (01-01-2022)“…To estimate inequalities in demand for family planning satisfied with modern methods among women in Latin America and the Caribbean, with an emphasis on Brazil…”
Get full text
Journal Article